Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review ; volume:23 ; number:1 ; day:11 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
Annals of general psychiatry ; 23, Heft 1 (11.11.2024), 1-10, 12.2024

Urheber
Lee, Serene
Li, Maggie
Le, Gia Han
Teopiz, Kayla M.
Vinberg, Maj
Ho, Roger
Au, Hezekiah C. T.
Wong, Sabrina
Valentino, Kyle
Kwan, Angela T. H.
Rosenblat, Joshua D.
McIntyre, Roger S.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12991-024-00527-9
URN
urn:nbn:de:101:1-2501282111569.699712480370
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lee, Serene
  • Li, Maggie
  • Le, Gia Han
  • Teopiz, Kayla M.
  • Vinberg, Maj
  • Ho, Roger
  • Au, Hezekiah C. T.
  • Wong, Sabrina
  • Valentino, Kyle
  • Kwan, Angela T. H.
  • Rosenblat, Joshua D.
  • McIntyre, Roger S.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

Hochschulschrift

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Verbundene Objekte